Parvigen, süstesuspensiooni pulber ja lahusti koertele
Parvigen, süstesuspensiooni pulber ja lahusti koertele
Authorised
- Canine parvovirus, strain Cornell 780916, Live
Product identification
Medicine name:
Parvigen, süstesuspensiooni pulber ja lahusti koertele
Active substance:
- Canine parvovirus, strain Cornell 780916, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parvovirus, strain Cornell 780916, Live10000000.00/tissue culture infective dose 501.00dose
Pharmaceutical form:
-
Powder and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- VIRBAC
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1363
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 15/02/2022
How useful was this page?:
